Serum Resistin as a Potential Mortality Predictor in Neonatal Sepsis
- PMID: 38562275
- PMCID: PMC10984556
- DOI: 10.7759/cureus.55289
Serum Resistin as a Potential Mortality Predictor in Neonatal Sepsis
Abstract
Aim The aim of this study was to investigate the utility of serum resistin levels as a prognostic indicator for mortality in neonates diagnosed with sepsis. Methodology This one-year prospective study at Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, India, included 151 neonates categorized into two groups based on blood culture results: group 1 (n=86) included those with culture-negative, probable sepsis and group 2 (n=65) included those with culture-positive, proven sepsis. Blood samples obtained pre-treatment underwent comprehensive analysis, including complete blood count, C-reactive protein assessment, micro-erythrocyte sedimentation rate, and resistin level measurement via enzyme-linked immunosorbent assay. The comparison between groups was conducted using either the Student t-test or the Mann-Whitney U test, while correlations were assessed using the Spearman correlation. These analyses were employed to identify the optimal resistin cut-off for distinguishing patients with sepsis. A p-value of <0.05 was considered statistically significant. Results This study with 151 neonates diagnosed with sepsis found a significant association (p < 0.05) between elevated serum resistin levels and increased mortality risk. Multivariate analysis confirmed an independent predictive role of resistin. Elevated resistin levels correlate with higher chances of requiring mechanical ventilation and prolonged hospital stays. These findings highlight serum resistin's potential as a prognostic tool for the early identification of high-risk neonatal sepsis patients. Conclusion This study highlights the link between elevated serum resistin levels and increased mortality risk in neonatal sepsis, supported by strong multivariate analysis, indicating an independent predictive role. Additionally, resistin correlates with higher chances of mechanical ventilation and prolonged hospitalization, suggesting its potential as a prognostic marker for early identification of high-risk neonatal sepsis cases.
Keywords: morbidity; mortality rate in sepsis; neonatal sepsis; pediatric disease; resistin.
Copyright © 2024, Jain et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
Utility of serum resistin in the diagnosis of neonatal sepsis and prediction of disease severity in term and late preterm infants.J Perinat Med. 2018 Oct 25;46(8):919-925. doi: 10.1515/jpm-2018-0018. J Perinat Med. 2018. PMID: 29605824
-
Diagnostic value of resistin and visfatin, in comparison with C-reactive protein, procalcitonin and interleukin-6 in neonatal sepsis.Eur Cytokine Netw. 2011 Jun;22(2):113-7. doi: 10.1684/ecn.2011.0283. Eur Cytokine Netw. 2011. PMID: 21636351
-
Can resistin be a new indicator of neonatal sepsis?Pediatr Neonatol. 2014 Feb;55(1):53-7. doi: 10.1016/j.pedneo.2013.04.012. Epub 2013 Jun 29. Pediatr Neonatol. 2014. PMID: 23820264
-
Resistin's, obesity and insulin resistance: the continuing disconnect between rodents and humans.J Endocrinol Invest. 2016 Jun;39(6):607-15. doi: 10.1007/s40618-015-0408-2. Epub 2015 Dec 12. J Endocrinol Invest. 2016. PMID: 26662574 Review.
-
Salivary resistin level and its association with insulin resistance in obese individuals.World J Diabetes. 2021 Sep 15;12(9):1507-1517. doi: 10.4239/wjd.v12.i9.1507. World J Diabetes. 2021. PMID: 34630903 Free PMC article. Review.
Cited by
-
Resistin as a potential diagnostic biomarker for sepsis: insights from DIA and ELISA analyses.Clin Proteomics. 2024 Jul 1;21(1):46. doi: 10.1186/s12014-024-09498-1. Clin Proteomics. 2024. PMID: 38951753 Free PMC article.
-
Development and internal validation of a metabolism-related model for predicting 30-day mortality in neonatal sepsis.BMC Infect Dis. 2025 Jan 27;25(1):121. doi: 10.1186/s12879-025-10527-z. BMC Infect Dis. 2025. PMID: 39871138 Free PMC article.
-
Serum Progranulin as a Potential Diagnostic Predictor in Neonatal Sepsis.Cureus. 2025 Jul 20;17(7):e88360. doi: 10.7759/cureus.88360. eCollection 2025 Jul. Cureus. 2025. PMID: 40687411 Free PMC article.
References
-
- Agarwal R, Deorari A, Paul V, Sankar MJ, Sachdeva A. Noble Vision. Vol. 1. Delhi: Noble Vision; 2019. AIIMS Protocols in Neonatology; pp. 303–315.
-
- An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Hofer N, Zacharias E, Müller W, Resch B. Neonatology. 2012;102:25–36. - PubMed
-
- A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection. Edgar JD, Gabriel V, Gallimore JR, McMillan SA, Grant J. BMC Pediatr. 2010;10:22. - PMC - PubMed
-
- Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis. Kocabaş E, Sarikçioğlu A, Aksaray N, Seydaoğlu G, Seyhun Y, Yaman A. https://pubmed.ncbi.nlm.nih.gov/17479639/ Turk J Pediatr. 2007;49:7–20. - PubMed
-
- The hormone resistin links obesity to diabetes. Steppan CM, Bailey ST, Bhat S, et al. Nature. 2001;409:307–312. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials